Sale!

Prevail Flunixin Megulmine Paste (30 g tube)

$27.89 $24.87

Apple Flavored Flunixin Meglumine Oral Paste for Relief of Pain, Inflammation and Fever in Horses.

Categories: , Tag: Prescription Required

Description

Prevail flunixin megulmine paste is used for the alleviation of inflammation and pain associated with musculoskeletal disorders in the horse.  Apple flavored oral paste for improved ease of administration.  Flunixin meglumine is a potent, nonnarcotic, nonsteroidal agent for relief of pain, inflammation and fever. Made by VetOne.

Additional information

Weight .13 lbs
Dimensions 1.25 x 2.0 x 9.0 in

More Details

This medication requires a prescription from your veterinarian.

Each syringe contains Flunixin Meglumine equivalent to 1500 mg Flunixin.

Formulations

Available in individual syringes containg 1500 mg flunixin in 30 g of apple flavored paste.

Administration

DOSAGE AND ADMINISTRATION: The recommended dose of flunixin meglumine is 0.5 mg per lb of body weight orally once daily. The Prevail™ Equine Paste syringe, calibrated in twelve 250-lb weight increments, delivers 125 mg of flunixin for each 250 lbs (see dosage table). One syringe will treat a 1000-lb horse once daily for 3 days, or three 1000-lb horses one time.

DOSAGE TABLE

Syringe Mark*

Horse Weight (lbs)

Prevail™ Equine Paste Delivered (g)

mg Flunixin Delivered

0

---

---

---

250

250

2.5

125

500

500

5.0

250

750

750

7.5

375

1000

1000

10.0

500

* Use dial edge nearest syringe barrel to mark dose.

Precautions

The effect of flunixin meglumine on pregnancy has not been determined. Studies to date show there is no detrimental effect on stallion spermatogenesis with or following the recommended dose of flunixin meglumine.

Manufacturer Product Information

VET ONE
Distributed by MWI Animal Health
3041 W. PASADENA DR., BOISE, ID, 83705
Customer Service: 888-694-8381
Toll-Free: 800-824-3703
Website: www.mwianimalhealth.com
Website: www.vetone.net

Every effort has been made to ensure the accuracy of the information published. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the USA product label or package insert.

PREVAIL™ EQUINE PASTE

VetOne

ANADA 200-591, Approved by FDA

(flunixin meglumine)

Apple Flavored

SYRINGE CONTAINS FLUNIXIN MEGLUMINE EQUIVALENT TO 1500 MG FLUNIXIN

FOR ORAL USE IN HORSES ONLY. KEEP OUT OF REACH OF CHILDREN

WARNING: Do not use in horses intended for human consumption.

CAUTION: Federal law restricts this drug to use by or on the order of a licensed veterinarian.

INDICATIONS: For the alleviation of inflammation and pain associated with musculoskeletal disorders in the horse.

ACTIVITY: Flunixin meglumine is a potent, nonnarcotic, nonsteroidal, analgesic agent with anti-inflammatory and antipyretic activity. It is significantly more potent than pentazocine, meperidine, and codeine as an analgesic in the rat yeast paw test. Oral studies in the horse show onset of flunixin activity occurs within 2 hours of administration. Peak response occurs between 12 and 16 hours and duration of activity is 24 to 36 hours.

CONTRAINDICATIONS: There are no known contraindications to this drug when used as directed.

PRECAUTIONS: The effect of flunixin meglumine on pregnancy has not been determined. Studies to date show there is no detrimental effect on stallion spermatogenesis with or following the recommended dose of flunixin meglumine.

SIDE EFFECTS: During field studies with flunixin meglumine, no significant side effects were reported.

DOSAGE AND ADMINISTRATION: The recommended dose of flunixin meglumine is 0.5 mg per lb of body weight once daily. The Prevail™ Equine Paste syringe, calibrated in twelve 250-lb weight increments, delivers 125 mg of flunixin for each 250 lbs (see dosage table). One syringe will treat a 1000-lb horse once daily for 3 days, or three 1000-lb horses one time.

DOSAGE TABLE

Syringe Mark*

Horse Weight (lbs)

Prevail™ Equine Paste Delivered (g)

mg Flunixin Delivered

0

---

---

---

250

250

2.5

125

500

500

5.0

250

750

750

7.5

375

1000

1000

10.0

500

* Use dial edge nearest syringe barrel to mark dose.

The paste is orally administered by inserting the nozzle of the syringe through the interdental space, and depositing the required amount of paste on the back of the tongue by depressing the plunger.

Treatment may be given initially by intravenous or intramuscular injection of Prevail™ Injectable Solution, followed by Prevail™ Equine Paste on Days 2 to 5. Flunixin meglumine treatment should not exceed 5 consecutive days.

TOXICITY: No toxic effects were observed in rats given oral flunixin meglumine 2 mg/kg per day for 42 days. Higher doses produced ulceration of the gastrointestinal tract. The emetic dose in dogs is between 150 and 250 mg/kg. Flunixin was well tolerated in monkeys dosed daily with 4 mg/kg for 56 days. No adverse effects occurred in horses dosed orally with 1.0 or 1.5 mg/lb for 5 consecutive days.

STORAGE: Store at 20°C - 25°C (69°F - 77°F); excursions permitted between 15°C - 30°C (between 59°F - 86°F).

Manufactured for: MWI, Boise, ID 83705, www.VetOne.net

Manufactured by: Bimeda-MTC Animal Health Inc., Cambridge, ON Canada N3C 2W4

Net Weight:

NDC

30 g

13985-707-15

V1 503018

1PRE003

8PRE004

Rev. 02/15

CPN: 1315207.0

Reviews

There are no reviews yet.

Be the first to review “Prevail Flunixin Megulmine Paste (30 g tube)”

You may also like…